Anavex Life Sciences Corp. (AVXL)
5.10
+0.07
(+1.39%)
USD |
NASDAQ |
Jan 21, 13:09
Anavex Life Sciences Free Cash Flow: -39.04M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CorMedix, Inc. | 74.42M |
| Verastem, Inc. | -140.93M |
| Ocugen, Inc. | -53.53M |
| AnaptysBio, Inc. | -145.42M |
| Replimune Group, Inc. | -269.69M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.604M |
| Cash from Financing (Quarterly) | 10.02M |
| Free Cash Flow Per Share (Quarterly) | -0.1002 |
| Free Cash Flow to Equity (Quarterly) | -8.604M |
| Free Cash Flow to Firm (Quarterly) | -8.604M |
| Free Cash Flow Yield | -8.98% |